The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effectiveness outcomes by treatment-free interval among patients receiving palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer in the real-world setting: Results from the PERFORM study.
 
Rupert Bartsch
Honoraria - Amgen; AstraZeneca; BMS GmbH & Co. KG; Daiichi Sankyo; Eisai; Gilead Sciences; Grunenthal; Lilly; MedMedia; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Stemline Therapeutics
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Grunenthal; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Stemline Therapeutics
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
 
Matthias Korell
Research Funding - Pfizer
 
Georg Pfeiler
Honoraria - Accord Healthcare; Amgen; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Gilead Sciences; Lilly; Menarini Group; Novartis; Pfizer; Roche/Genentech; Seagen; UCB
Consulting or Advisory Role - Amgen; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Roche/Genentech; Seagen; UCB
Speakers' Bureau - Accord Healthcare; Amgen; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Gilead Sciences; Lilly; Novartis; Pfizer; Roche/Genentech; Seagen; UCB
Research Funding - Accord Healthcare; AstraZeneca (Inst); Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Accord Research; AstraZeneca/Daiichi Sankyo; Gilead Sciences; Lilly; Lilly; Merck; Novartis; Pfizer; Roche/Genentech; Seagen
 
Thomas Gabrysiak
Research Funding - Pfizer (Inst)
 
Thomas Fietz
Consulting or Advisory Role - BMS GmbH & Co. KG; GlaxoSmithKline; Incyte; SOBI
Speakers' Bureau - SOBI
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - AOP-Health; BeiGene; Novartis
 
Mustafa Deryal
Employment - CaritasKlinikum Saarbruecken
Research Funding - Pfizer (Inst)
 
Volker Petersen
Research Funding - Pfizer
 
Thomas Resch
Research Funding - Pfizer
 
Bjoern Schoettker
Research Funding - BeOne; Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Thomas Decker
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Lilly; Novartis
Speakers' Bureau - Roche/Genentech
Research Funding - Pfizer Hellas
 
Lothar Müller
Honoraria - Pierre Fabre; Roche
Consulting or Advisory Role - Roche
Research Funding - Pfizer
Expert Testimony - Roche
Travel, Accommodations, Expenses - Octapharm; Pierre Fabre; Roche
 
Julia Radosa
Honoraria - AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gedeon Richter; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Stemline Therapeutics; Theramex
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gedeon Richter; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Stemline Therapeutics; Theramex
Research Funding - Pfizer (Inst)
Expert Testimony - AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gedeon Richter; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Stemline Therapeutics; Theramex
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Medac; Pfizer; Pierre Fabre; Seagen
 
Uwe Rhein
Research Funding - Pfizer
 
Martin Glasstetter
Employment - iOMEDICO
 
Dunja Klein
Employment - iOMEDICO
 
Anna Buder
Employment - Pfizer Corporation Austria Gesellschaft m.b.H.
Stock and Other Ownership Interests - Pfizer
 
Hagen Krueger
Employment - Pfizer
Leadership - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Azita Quartier
Employment - Pfizer PIO
Stock and Other Ownership Interests - Pfizer
 
Johanna Dzieran
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Michael Lux
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Endomag; Genomic Health; Gilead Sciences; Gilead Sciences; Grunenthal; Hexal; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; SamanTree Medical
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; Endomag; Genomic Health; Gilead Sciences; Grunenthal; Hexal; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche Pharma AG
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai Germany; Endomag; Exact Sciences; Gilead Sciences; Grunenthal; Lilly; MSD Oncology; Novartis; Pfizer; pfm medical; Roche Pharma AG
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); German Breast Group (Inst); Gilead Sciences; Grunenthal (Inst); MSD Oncology (Inst); PRAEGNANT Network (Inst); Roche (Inst); SamanTree Medical (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi-Sankyo; Gilead Sciences; Menarini; Pfizer; Roche Pharma AG
Other Relationship - Medac
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Endomag; Grunenthal; Pfizer